SCHEMBL1268801

SCHEMBL1268801

Cc1nc(NS(=O)(=O)c2ccc(Cl)cc2)ncc1Oc1ccc(S(=O)(=O)N2CCOCC2)cc1

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.52
▸ GLA P06280 1/20 0.52
▸ LMNA P02545 6/20 0.49
▸ SMN1; SMN2 Q16637 6/20 0.49
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ GAA P10253 1/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ HTT P42858 2/20 0.46
▸ POLB P06746 1/20 0.46
▸ MAPT P10636 1/20 0.46
▸ NOD2 Q9HC29 1/20 0.46
▸ TSHR P16473 1/20 0.45
▸ HSD17B10 Q99714 2/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ HPGD P15428 1/20 0.44
▸ RAB9A P51151 1/20 0.43
▸ ATM Q13315 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1268653 0.90 SMN1; SMN2 (0.45) ALDH1A1GLALMNASMN1; SMN2L3MBTL1
SCHEMBL1269625 0.87 ALDH1A1 (0.51) ALDH1A1GLALMNASMN1; SMN2L3MBTL1
SCHEMBL1269442 0.86 ALDH1A1 (0.50) ALDH1A1GLALMNASMN1; SMN2L3MBTL1
SCHEMBL1269492 0.83 GAA (0.48) ALDH1A1GLALMNASMN1; SMN2GAA
SCHEMBL12931666 0.81 ALDH1A1 (0.45) ALDH1A1GLALMNASMN1; SMN2GAA
SCHEMBL1472315 0.78 ALDH1A1 (0.72) ALDH1A1GLALMNASMN1; SMN2KMT2A
SCHEMBL1268839 0.73 MEN1 (0.42) ALDH1A1GLALMNASMN1; SMN2GAA
SCHEMBL1269828 0.72 ALDH1A1 (0.45) ALDH1A1LMNASMN1; SMN2L3MBTL1KMT2A
SCHEMBL5307467 0.71 POLB (0.73) ALDH1A1LMNASMN1; SMN2L3MBTL1GAA
SCHEMBL5915275 0.69 POLB (0.71) ALDH1A1LMNASMN1; SMN2L3MBTL1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7893077-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2011-02-22 — — US disclosed
US-7893077-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2011-02-22 — — US disclosed
US-7893077-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2011-02-22 — — US disclosed
EP-1786782-B1 BISARYL-SULFONAMIDES AMGEN INC (US) 2010-03-31 — — EP disclosed
US-20090221584-A1 Bisaryl-sulfonamides AMGEN INC. 2009-09-03 — — US disclosed
US-20090221584-A1 Bisaryl-sulfonamides AMGEN INC. 2009-09-03 — — US disclosed
US-20090221584-A1 Bisaryl-sulfonamides AMGEN INC. 2009-09-03 — — US disclosed
US-7544702-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2009-06-09 — — US disclosed
US-7544702-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2009-06-09 — — US disclosed
US-7544702-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2009-06-09 — — US disclosed
US-20060084802-A1 Bisaryl-sulfonamides AMGEN INC. 2006-04-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090221584-A1 Bisaryl-sulfonamides PPARD, PPARA, PPARG ALDH1A1 2237/4885GLA 659/4885LMNA 2576/4885
US-20060084802-A1 Bisaryl-sulfonamides PPARD, PPARA, PPARG ALDH1A1 2237/4885GLA 659/4885LMNA 2576/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback